What is the 13F Pro Quality Score for PEPG?

13F Pro ranks PepGen Inc. (PEPG) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View PEPG's current score at https://13fpro.ai/research/PEPG (free sign-up required for the full ranking).

Where does 13F Pro source PEPG data?

All PepGen Inc. fundamentals and ownership data come directly from SEC EDGAR. PepGen Inc. files with the SEC under CIK 1835597. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is PEPG in?

PepGen Inc. (PEPG) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is PEPG research updated on 13F Pro?

PEPG's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

PepGen Inc.(PEPG)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1835597 PEPG stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.0M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

PEPG Stock Analysis & AI Quality Score

AI stock analysis and institutional research for PepGen Inc. (PEPG), a Healthcare sector company. PEPG is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.0m in revenue. Based on the latest XBRL financial filings (Q1 2026), PepGen Inc. reports net income of $-17.8M, free cash flow of $-18.4M. Top institutional holders of PEPG by reported 13-F value include RA CAPITAL MANAGEMENT, L.P., Commodore Capital, VIKING GLOBAL INVESTORS, based on the most recent SEC filings. PEPG trades on the Nasdaq exchange and files with the SEC under CIK 1835597. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PEPG daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for PepGen Inc. directly from SEC EDGAR.

Net Income

Q1 2026

$-17.8M

Free Cash Flow

Q1 2026

$-18.4M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Net Income

-229.8% YoY

$-90.0MFY 2024

FY21 $-27.3MFY24 $-90.0M

Operating Income

-260.5% YoY

$-97.7MFY 2024

FY21 $-27.1MFY24 $-97.7M

EPS (Diluted)

+90.4% YoY

$-1.43FY 2024

FY21 $-14.87FY24 $-1.43

Total Assets

+5.0% YoY

$150.9MFY 2024

FY21 $143.6MFY24 $150.9M

Op. Cash Flow

-264.5% YoY

$-82.4MFY 2024

FY21 $-22.6MFY24 $-82.4M

Metric	FY 2024	FY 2021
Net Income	$-90.0M -229.8%	$-27.3M
Operating Income	$-97.7M -260.5%	$-27.1M
EPS (Diluted)	$-1.43 +90.4%	$-14.87
Total Assets	$150.9M +5.0%	$143.6M
Operating Cash Flow	$-82.4M -264.5%	$-22.6M

AI Insight: PEPG Financial Trends

PepGen's operating losses have stabilized around $18–20M quarterly since Q3 2025, but equity erosion and a mysterious debt spike in Q3 2025 require clarification.

• Operating losses narrowed from $31M (Q1 2025) to $19M (Q1 2026), suggesting burn-rate improvement over recent quarters.

• Operating cash flow stabilized at $16–19M negative since Q3 2025, versus $23–24M negative in prior quarters.

• Equity declined from $155M (Q2 2024) to $134M (Q1 2026), a 13.5% erosion driven by cumulative net losses.

⚠ Total debt surged to $163M in Q3 2025 from $71M in Q2 2025—a $92M increase unexplained by available data.

⚠ No revenue data disclosed across all periods; profitability path and commercial progress remain opaque.

AI Insight: PEPG Ratio Trends

PepGen remains deeply unprofitable, though ROE and ROA showed material improvement from Q1–Q2 2025 lows but deteriorated again in recent quarters.

• ROE improved sharply from -131.6% (Q1 2025) to -44.2% (Q3 2025), a 87.4pp swing, then softened to -53.0% (Q1 2026).

• ROA followed similar pattern: crashed to -94.8% (Q1 2025), recovered to -37.9% (Q3 2025), slipped to -45.5% (Q1 2026).

• ROIC data gaps in Q1–Q2 2025 resume in Q3 2025 at -45.7%, deteriorating to -56.5% by Q1 2026.

⚠ Q1 2026 returns worsened vs. Q3 2025: ROE fell 8.8pp, ROA fell 7.6pp, ROIC fell 10.8pp—reversing improvement trend.

⚠ No operating margin, NPM, or leverage data across all periods limits visibility into cost structure and capital efficiency.

Get alerted when PEPG's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for PepGen Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of PEPG

RA CAPITAL MANAGEMENT, L.P.
$35.5M20,064,545 sh
Commodore Capital LP
$7.9M4,475,000 sh
VIKING GLOBAL INVESTORS LP
$6.2M3,482,434 sh
Laurion Capital Management LP
$4.9M2,750,855 sh
Vivo Capital, LLC
$4.1M2,325,000 sh
MILLENNIUM MANAGEMENT LLC
$3.7M2,079,143 sh
VANGUARD CAPITAL MANAGEMENT LLC
$3.4M1,937,699 sh
AWM Investment Company, Inc.
$3.2M1,830,925 sh
ADAR1 Capital Management, LLC
$2.8M1,607,638 sh
Woodline Partners LP
$2.3M1,311,021 sh

Fund	Value	Shares
RA CAPITAL MANAGEMENT, L.P.	$35.5M	20,064,545
Commodore Capital LP	$7.9M	4,475,000
VIKING GLOBAL INVESTORS LP	$6.2M	3,482,434
Laurion Capital Management LP	$4.9M	2,750,855
Vivo Capital, LLC	$4.1M	2,325,000
MILLENNIUM MANAGEMENT LLC	$3.7M	2,079,143
VANGUARD CAPITAL MANAGEMENT LLC	$3.4M	1,937,699
AWM Investment Company, Inc.	$3.2M	1,830,925
ADAR1 Capital Management, LLC	$2.8M	1,607,638
Woodline Partners LP	$2.3M	1,311,021

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put PEPG on your watchlist

Track score changes the day PepGen Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is PEPG a good stock to buy?

13F Pro's AI-powered analysis of PepGen Inc. (PEPG) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for PEPG are available on the PEPG stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own PEPG?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling PEPG. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of PepGen Inc.'s investment landscape.